Rationale and Design of the Future Optimal Research and Care Evaluation in Patients with Acute Coronary Syndrome (FORCE-ACS) Registry: Towards "Personalized Medicine" in Daily Clinical Practice

Dean R P P Chan Pin Yin, Gert-Jan A Vos, Niels M R van der Sangen, Ronald Walhout, R Melvyn Tjon Joe Gin, Deborah M Nicastia, Jorina Langerveld, Daniël M F Claassens, Marieke E Gimbel, Jaouad Azzahhafi, Willem L Bor, Tom Oirbans, Johan Dekker, Georgios J Vlachojannis, Rutger J van Bommel, Yolande Appelman, José P S Henriques, Wouter J Kikkert, Jurriën M Ten Berg, Dean R P P Chan Pin Yin, Gert-Jan A Vos, Niels M R van der Sangen, Ronald Walhout, R Melvyn Tjon Joe Gin, Deborah M Nicastia, Jorina Langerveld, Daniël M F Claassens, Marieke E Gimbel, Jaouad Azzahhafi, Willem L Bor, Tom Oirbans, Johan Dekker, Georgios J Vlachojannis, Rutger J van Bommel, Yolande Appelman, José P S Henriques, Wouter J Kikkert, Jurriën M Ten Berg

Abstract

Diagnostic and treatment strategies for acute coronary syndrome have improved dramatically over the past few decades, but mortality and recurrent myocardial infarction rates remain high. An aging population with increasing co-morbidities heralds new clinical challenges. Therefore, in order to evaluate and improve current treatment strategies, detailed information on clinical presentation, treatment and follow-up in real-world patients is needed. The Future Optimal Research and Care Evaluation in patients with Acute Coronary Syndrome (FORCE-ACS) registry (ClinicalTrials.gov Identifier: NCT03823547) is a multi-center, prospective real-world registry of patients admitted with (suspected) acute coronary syndrome. Both non-interventional and interventional cardiac centers in different regions of the Netherlands are currently participating. Patients are treated according to local protocols, enabling the evaluation of different diagnostic and treatment strategies used in daily practice. Data collection is performed using electronic medical records and quality-of-life questionnaires, which are sent 1, 12, 24 and 36 months after initial admission. Major end points are all-cause mortality, myocardial infarction, stent thrombosis, stroke, revascularization and all bleeding requiring medical attention. Invasive therapy, antithrombotic therapy including patient-tailored strategies, such as the use of risk scores, pharmacogenetic guided antiplatelet therapy and patient reported outcome measures are monitored. The FORCE-ACS registry provides insight into numerous aspects of the (quality of) care for acute coronary syndrome patients.

Keywords: acute coronary syndrome; antiplatelet therapy; multicenter registry.

Conflict of interest statement

J.P.S.H. has received unrestricted grants from AstraZeneca; W.J.K. has received research grants and speaker fees from AstraZeneca; J.M.t.B. has received research grants from ZonMw and AstraZeneca and Advisory/consulting/speaker fees from AstraZeneca, Eli Lilly, Daiichi Sankyo, The Medicines Company, Accu-Meterics, Boehringer Ingelheim, BMS, Pfizer, Payer, Ferrer, Idorsia. D.R.P.P.C.P.Y., G.-J.A.V., N.M.R.v.d.S., R.W., R.M.T.J.G., D.M.N., J.L., D.M.F.C., M.E.G., J.A., W.L.B., T.O., J.D., G.J.V., R.J.v.B. and Y.A. declare to have no conflict of interest. The funders had no role in the design of the study or in the writing of the manuscript.

Figures

Figure 3
Figure 3
Flowchart illustrating decision-making regarding the optimal treatment duration with dual antiplatelet therapy using risk scores. Abbreviations: ACS, acute coronary syndrome; DAPT, Dual AntiPlatelet Therapy.
Figure 1
Figure 1
Geographical locations of cardiac centers participating in the Future Optimal Research and Care Evaluation in patients with Acute Coronary Syndrome (FORCE-ACS) registry.
Figure 2
Figure 2
Flowchart illustrating data collection in the in Future Optimal Research and Care Evaluation in patients with Acute Coronary Syndrome (FORCE-ACS) registry. Abbreviations: CABG, coronary artery bypass grafting; CV, cardiovascular; PCI, percutaneous coronary intervention; and SF, short form.

References

    1. Szummer K., Wallentin L., Lindhagen L., Alfredsson J., Erlinge D., Held C., James S., Kellerth T., Lindahl B., Ravn-Fischer A., et al. Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: Experiences from the SWEDEHEART registry 1995–2014. Eur. Heart J. 2017;38:3056–3065. doi: 10.1093/eurheartj/ehx515.
    1. Szummer K., Wallentin L., Lindhagen L., Alfredsson J., Erlinge D., Held C., James S., Kellerth T., Lindahl B., Ravn-Fischer A., et al. Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: Experiences from SWEDEHEART registry 1995 to 2014. Eur. Heart J. 2018;39:3766–3776. doi: 10.1093/eurheartj/ehy554.
    1. Fox K.A.A., Carruthers K.F., Dunbar D.R., Graham C., Manning J.R., De Raedt H., Buysschaert I., Lambrechts D., Van De Werf F. Underestimated and under-recognized: The late consequences of acute coronary syndrome (GRACE UK-Belgian Study) Eur. Heart J. 2010;31:2755–2764. doi: 10.1093/eurheartj/ehq326.
    1. Jernberg T., Hasvold P., Henriksson M., Hjelm H., Thuresson M., Janzon M. Cardiovascular risk in post-myocardial infarction patients: Nationwide real world data demonstrate the importance of a long-term perspective. Eur. Heart J. 2015;36:1163–1170. doi: 10.1093/eurheartj/ehu505.
    1. Simonsson M., Wallentin L., Alfredsson J., Erlinge D., Hellstrom Angerud K., Hofmann R., Kellerth T., Lindhagen L., Ravn-Fischer A., Szummer K., et al. Temporal trends in bleeding events in acute myocardial infarction: Insights from the SWEDEHEART registry. Eur. Heart J. 2020;41:833–843. doi: 10.1093/eurheartj/ehz593.
    1. Valgimigli M., Bueno H., Byrne R.A., Collet J.-P., Costa F., Jeppsson A., Juni P., Kastrati A., Kolh P., Mauri L., et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS) Eur. Heart J. 2018;39:213–260. doi: 10.1093/eurheartj/ehx419.
    1. Costa F., van Klaveren D., James S., Heg D., Räber L., Feres F., Pilgrim T., Hong M.K., Kim H.S., Colombo A., et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: A pooled analysis of individual-patient datasets from clinical trials. Lancet. 2017;389:1025–1034. doi: 10.1016/S0140-6736(17)30397-5.
    1. Yeh R.W., Secemsky E.A., Kereiakes D.J., Normand S.L.T., Gershlick A.H., Cohen D.J., Spertus J.A., Steg P.G., Cutlip D.E., Rinaldi M.J., et al. Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA. 2016;315:1735–1749. doi: 10.1001/jama.2016.3775.
    1. Alexander K.P., Newby L.K., Cannon C.P., Armstrong P.W., Gibler W.B., Rich M.W., Van de Werf F., White H.D., Weaver W.D., Naylor M.D., et al. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: A scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: In collaboration with the Society of Geriatric Cardiology. Circulation. 2007;115:2549–2569. doi: 10.1161/CIRCULATIONAHA.107.182615.
    1. GRACE Investigators Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromes. Am. Heart J. 2001;141:190–199. doi: 10.1067/mhj.2001.112404.
    1. Aliprandi-Costa B., Ranasinghe I., Turnbull F., Brown A., Kritharides L., Patel A., Chew D., Walters D., Rankin J., Ilton M., et al. The design and rationale of the Australian Cooperative National Registry of Acute Coronary care, Guideline Adherence and Clinical Events (CONCORDANCE) Heart. Lung Circ. 2013;22:533–541. doi: 10.1016/j.hlc.2012.12.013.
    1. Hao Y., Liu J., Liu J., Smith S.C.J., Huo Y., Fonarow G.C., Ma C., Ge J., Taubert K.A., Morgan L., et al. Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome. Am. Heart J. 2016;179:107–115. doi: 10.1016/j.ahj.2016.06.005.
    1. Alegre O., Ariza-Sole A., Vidan M.T., Formiga F., Martinez-Selles M., Bueno H., Sanchis J., Lopez-Palop R., Abu-Assi E., Cequier A. Impact of frailty and other geriatric syndromes on clinical management and outcomes in elderly patients with non-ST-segment elevation Acute Coronary Syndromes: Rationale and design of the LONGEVO-SCA registry. Clin. Cardiol. 2016;39:373–377. doi: 10.1002/clc.22550.
    1. Fokkema M.L., James S.K., Albertsson P., Aasa M., Akerblom A., Calais F., Eriksson P., Jensen J., Schersten F., de Smet B.J., et al. Outcome after percutaneous coronary intervention for different indications: Long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) EuroIntervention. 2016;12:303–311. doi: 10.4244/EIJY15M10_07.
    1. Roffi M., Patrono C., Collet J.P., Mueller C., Valgimigli M., Andreotti F., Bax J.J., Borger M.A., Brotons C., Chew D.P., et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur. Heart J. 2016;37:267–315. doi: 10.1093/eurheartj/ehv320.
    1. Ibanez B., James S., Agewall S., Antunes M.J., Bucciarelli-Ducci C., Bueno H., Caforio A.L.P., Crea F., Goudevenos J.A., Halvorsen S., et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society. Eur. Heart J. 2018;39:119–177. doi: 10.1093/eurheartj/ehx393.
    1. Neumann F.-J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., Byrne R.A., Collet J.-P., Falk V., Head S.J., et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2019;40:87–165. doi: 10.1093/eurheartj/ehy394.
    1. Knuuti J., Wijns W., Saraste A., Capodanno D., Barbato E., Funck-Brentano C., Prescott E., Storey R.F., Deaton C., Cuisset T., et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 2020;41:407–477. doi: 10.1093/eurheartj/ehz425.
    1. Harris P.A., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J.G. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 2009;42:377–381. doi: 10.1016/j.jbi.2008.08.010.
    1. Ware J.J., Kosinski M., Keller S.D. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med. Care. 1996;34:220–233. doi: 10.1097/00005650-199603000-00003.
    1. Spertus J.A., Winder J.A., Dewhurst T.A., Deyo R.A., Prodzinski J., McDonell M., Fihn S.D. Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. J. Am. Coll. Cardiol. 1995;25:333–341. doi: 10.1016/0735-1097(94)00397-9.
    1. Mehran R., Rao S.V., Bhatt D.L., Gibson C.M., Caixeta A., Eikelboom J., Kaul S., Wiviott S.D., Menon V., Nikolsky E., et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the bleeding academic research consortium. Circulation. 2011;123:2736–2747. doi: 10.1161/CIRCULATIONAHA.110.009449.
    1. Garcia-Garcia H.M., McFadden E.P., Farb A., Mehran R., Stone G.W., Spertus J., Onuma Y., Morel M.-A., van Es G.-A., Zuckerman B., et al. Standardized end point definitions for coronary intervention trials: The Academic Research Consortium-2 consensus document. Circulation. 2018;137:2635–2650. doi: 10.1161/CIRCULATIONAHA.117.029289.
    1. Taqueti V.R. Sex differences in the coronary system. Adv. Exp. Med. Biol. 2018;1065:257–278. doi: 10.1007/978-3-319-77932-4_17.
    1. Tra J., van der Wulp I., Appelman Y., de Bruijne M.C., Wagner C. Adherence to guidelines for the prescription of secondary prevention medication at hospital discharge after acute coronary syndrome: A multicentre study. Neth. Heart J. 2015;23:214–221. doi: 10.1007/s12471-015-0664-y.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться